Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a three-year prospective study

Author:

Jada Stephen Raimon1,Amaral Luís-Jorge2,Lakwo Thomas3,Carter Jane Y1,Rovarini Jacopo1,Bol Yak Yak4,Logora Makoy Yibi4,Hadermann Amber2,Hopkins Adrian5,Fodjo Joseph N Siewe2,Colebunders Robert6ORCID

Affiliation:

1. AMREF: Amref Health Africa

2. Global Health Institute University of Antwerp

3. Republic of Uganda Ministry of Health

4. Ministry of Health South Sudan

5. Onchocerciasis elimination advisory committee South Sudan

6. Universiteit Antwerpen

Abstract

Abstract Background High onchocerciasis transmission predisposes endemic communities to a high epilepsy burden. Retrospective studies suggest that adequate onchocerciasis control would decrease the epilepsy burden, but this has never been assessed prospectively. The 4.4% (95% CI: 4.1–4.7%) epilepsy prevalence documented in 2018 in the onchocerciasis focus in Maridi, South Sudan, prompted the strengthening of onchocerciasis elimination measures. We evaluated the effect of these interventions on the incidence of epilepsy, including nodding syndrome (NS). Methods Community-directed treatment with ivermectin (CDTi) was implemented annually in 2017, 2018 and 2019, interrupted in 2020 and re-implemented biannually in 2021. Additionally, a community-based “Slash and Clear” vector control method was initiated in 2019 at the Maridi dam, the main blackfly breeding site. Community-based surveys were conducted in Maridi in 2018 (baseline) and 2022 (follow-up) to investigate changes in epilepsy incidence following onchocerciasis elimination interventions. Epilepsy was confirmed via a two-stage approach: the house-to-house screening of all residents followed by confirmation of the epilepsy diagnosis by trained clinicians. Results The baseline and follow-up surveys included 17,652 and 14,402 individuals, respectively. When biannual CDTi was initiated in 2021, CDTi coverage rose by 15.7% (95% CI: 14.6–16.8%); still, only 56.6% of the population took ivermectin in 2021. Between 2018 and 2022, epilepsy incidence decreased from 348.8 (95% CI: 307.2–395.8) to 41.7 (95% CI: 22.6–75.0) per 100,000 person-years. Similarly, the incidence of NS decreased from 154.7 (95% CI: 127.6–187.3) to 10.4 (95% CI: 2.7–33.2) per 100,000 person-years. Living closer to the Maridi dam, being aged 6–40 years, not taking ivermectin and being male constituted risk factors for epilepsy. Conclusions In onchocerciasis-endemic areas with high epilepsy prevalence, strengthening onchocerciasis elimination interventions can decrease the incidence of epilepsy, including NS. Additional efforts are needed to increase CDTi coverage and sustain blackfly control in Maridi.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3